---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-025349"
form_type: "8-K"
ticker: "TOI"
cik: "0001799191"
company_name: "Oncology Institute, Inc."
filed_at: "2022-09-22T23:59:59+00:00"
generated_at: "2026-06-23T08:04:11.058312+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Oncology Institute appoints Mark Pacala and Gabe Ling to Board, expanding to 9 members

## Summary
- Mark Pacala brings >30 yrs healthcare management/PE experience; former CEO of Forum Group and American Whole Health.
- Gabe Ling is co-founder of M33 Growth, a principal stockholder; previously partner at General Catalyst.
- Appointments effective immediately; new directors will serve until 2023 Annual Meeting.
- Neither director will serve on any committee; Pacala determined independent; Ling affiliated with M33.
- Compensation will follow standard non-employee director policy as disclosed in 10-K.

## SEC filing metadata
- accession: 0001628280-22-025349
- form_type: 8-K
- ticker: TOI
- cik: 0001799191
- company_name: Oncology Institute, Inc.
- filed_at: 2022-09-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1799191/000162828022025349/0001628280-22-025349-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1799191/000162828022025349/toi-20220921.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-025349
- JSON: https://secwatch.observer/filing/0001628280-22-025349.json
- Plain text: https://secwatch.observer/filing/0001628280-22-025349.txt

## Key facts
- Executive change
  Mark Pacala was appointed as Director at Oncology Institute, Inc..
  - Action: appointed
  - Role: Director
  source text: the Board appointed Mr. Mark Pacala and Mr. Gabriel Ling to the Board, effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000162828022025349/0001628280-22-025349-index.htm
- Executive change
  Gabriel Ling was appointed as Director at Oncology Institute, Inc..
  - Action: appointed
  - Role: Director
  source text: the Board appointed Mr. Mark Pacala and Mr. Gabriel Ling to the Board, effective immediately
  evidence_url: https://www.sec.gov/Archives/edgar/data/1799191/000162828022025349/0001628280-22-025349-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.